Absolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer: TEXT and SOFT trials - Regan, M M; Francis, P A; Pagani, O (J Clin Oncol, 2016)
et al.